MedTrace Logo

Impact of isoQUercetin and Aspirin on Platelet Function

NCT02866448 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2016-11-29

No results posted yet for this study

Summary

The purpose of this study is to investigate the effect of acute isoquercetin supplementation, aspirin, and isoquercetin/aspirin combination on platelet aggregation, blood pressure and vasculat stiffness (eg digital volume pulse), as well as investigating the plasma accumulation and urine excretion profiles of quercetin.

Conditions

Interventions

DRUG

Vehicle control

Described in arm

DRUG

Isoquercetin

Described in arm

DRUG

Aspirin

Described in arm

DRUG

Isoquercetin plus Aspirin

Described in arm

Sponsors & Collaborators

  • Biotechnology and Biological Sciences Research Council

    collaborator OTHER

  • Quercegen Pharmaceuticals

    collaborator INDUSTRY

  • University of Reading

    lead OTHER

Principal Investigators

  • Julie A Lovegrove, BSc PhD RNutr · University of Reading

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02866448 on ClinicalTrials.gov